2019 Mezhir grant awards named for Holden Comprehensive Cancer Center members

Thanks to the continued generosity of the Holden Family, Holden Comprehensive Cancer Center is able to support the development of multi-investigator team science to address important research questions in cancer. This award honors the memory of the late James Mezhir, MD, a former member of the cancer center who died in 2016.

The research focus of collaborative teams can address any cancer-relevant topic in basic, translational, clinical, or population science.

New awards

“Radiation Exposure and Cardiac Arrhythmias: Mechanisms and Mitigation”

Isabella Grumbach, MD, PhD

“Risk Communication using Novel Biomarkers to Facilitate Smoking Cessation in Patients Undergoing Lung Cancer Screening”

  • Mark Vander Weg, PhD, associate professor, internal medicine, Cancer Epidemiology and Population Science member
  • Amount: $100,000

Mark Vander Weg, PhD

Continued funding awards

“Targeting Drug Resistance in Melanoma” (original title)

  • Adam Dupuy, PhD, associate professor, anatomy and cell biology, Cancer Genes and Pathways member
  • Amount: $50,000

Adam Dupuy, PhD

“Targeting RB1 Pathway in NF1 Tumors”

  • Dawn Quelle, PhD, professor, pharmacology, Cancer Genes and Pathways leader/member
  • Amount: $50,000

Dawn Quelle, PhD